Guidance

Human papillomavirus (HPV) vaccine, adolescent females: PGD template

Patient group direction (PGD) template to support the national human papillomavirus (HPV) vaccination programme for adolescent females.

From:
Public Health England
Published
28 April 2016
Last updated
10 April 2018 — See all updates

This publication was withdrawn on

From 1 September 2019 the national HPV vaccination programme is being extended to eligible boys. Please use the revised Human papillomavirus (HPV) vaccine: PGD template.

Documents

[Withdrawn] Human papillomavirus (HPV) vaccine, adolescent females: patient group direction (PGD) template

Ref: PHE publications gateway number 2016044

MS Word Document, 116 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of HPV vaccine to girls from 12 years of age or from school year 8 in accordance with the national immunisation programme.

It is valid from 1 May 2018 to 30 April 2020.

Practitioners must not use this PGD template until it has been authorised in Section 2. This is a legal requirement (see Human Medicines Regulations 2012). Practitioners should follow local policy/procedures to access authorised PGD documents.

This PGD template should be used with reference to current national guidance, the Green Book, and Summary of Product Characteristics for the vaccine.

Published 28 April 2016
Last updated 10 April 2018 + show all updates

  1. Added revised PGD valid from 1 May 2018.

  2. First published.

Related content